This glossary is provided for general educational purposes only and is not intended to promote or advertise any therapeutic good
Discussions about vaping often include technical terms that can be confusing. This glossary outlines commonly used terminology in a neutral, regulatory context.
Nicotine vaping products are regulated in Australia as prescription-only therapeutic goods. Understanding terminology does not imply endorsement or promotion of use.
Aerosol
The vapour produced when a vaping device heats liquid. It is inhaled by the user.
Atomiser
The component of a vaping device that heats liquid to create an aerosol.
Battery
The power source used to operate a vaping device. Many devices contain lithium-ion batteries, which are subject to aviation safety restrictions.
Cartridge / Pod
A container that holds vaping liquid. Some systems are refillable; others are pre-filled.
Coil
A heating element within a vaping device that vaporises liquid.
E-Liquid
A liquid used in vaping devices. It may contain nicotine, flavourings and base ingredients such as propylene glycol or vegetable glycerine.
Nicotine
A stimulant substance found in tobacco. In Australia, nicotine for use in vaping products is classified as a prescription-only medicine.
Nicotine Concentration (mg/mL)
Refers to the amount of nicotine contained in a liquid per millilitre. Suitability should be assessed by a qualified healthcare professional.
Propylene Glycol (PG)
A base ingredient commonly used in vaping liquids. It contributes to aerosol formation and flavour delivery.
Vegetable Glycerine (VG)
Another base ingredient used in vaping liquids. It contributes to aerosol density.
Prescription-Only Medicine
In Australia, nicotine vaping products are regulated under the Therapeutic Goods Act as prescription-only medicines. Supply requires authorisation from a registered medical practitioner. They are not approved as first-line smoking cessation therapies
Second-Line Treatment
In the context of smoking cessation, a treatment that may be considered after first-line therapies have been unsuccessful, under medical supervision. In some clinical contexts, healthcare professionals may consider a range of management approaches based on individual circumstances.
Therapeutic Goods Administration (TGA)
The Australian regulatory authority responsible for regulating therapeutic goods, including nicotine vaping products.
Dual Use
The concurrent use of tobacco cigarettes and vaping products. Dual use is not recommended.
Important Information
Nicotine vaping products are not risk-free. Evidence regarding long-term safety continues to evolve.
Individuals considering smoking cessation options should consult a qualified healthcare professional to determine the most appropriate approach based on their individual health circumstances.
Disclaimer
Nicotine vaping products are prescription-only medicines in Australia and are regulated therapeutic goods.
Information provided here is for general educational purposes only and does not constitute medical advice.
DISCLAIMER: There are a number of ways to quit smoking. We have a range of tools that may help with smoking cessation such as nicotine patches, gums and vaping products. Vaping products, used as second-line tools may be useful for those who have not successfully quit smoking using traditional methods.
It’s important to acknowledge there’s limited available evidence on the efficacy, safety or long-term health effects of nicotine vaping products. There are potential side effects associated with vaping. Long-term vaping and dual-use (smoking and vaping concurrently) is not recommended and should be avoided. Regular review and monitoring by your regular GP is advised along your smoking cessation journey.
Research on smoking cessation methods, including prescription nicotine vaping products, continues to expand as new evidence emerges.
There are several evidence-based approaches available to support smoking cessation, including nicotine replacement therapy and behavioural support.
Research into the health effects of vaping is ongoing, with current evidence highlighting both known risks and areas where long-term outcomes remain uncertain.
Research into the side effects of vaping is ongoing, with reported symptoms varying between individuals and long-term health effects still under investigation.
First Nations Acknowledgement
We acknowledge the Traditional Owners of Country throughout Australia. We pay our respects to Elders past and present.
Nicotine is addictive, and the long term-risks of vaping are unknown. Complete abstinence from smoking and vaping is the safest for your health. Currently no nicotine vaping products have been approved by the TGA, and the safety of these products has not been determined. Long-term vaping and dual-use (smoking and vaping concurrently) must be avoided. Vaped nicotine products are only recommended for individuals that have tried but failed to quit smoking using approved first line smoking cessation therapies.Must be over 18 years old, not for use in pregnancy or breastfeeding. Regular review and monitoring by your regular GP is advised along your smoking cessation journey
*To apply for your nicotine vape prescription please complete this FREE virtual consultation. If eligible, you will be requested to make a $20 script payment. This $20 fee will be credited towards your first purchase with Help Me Stop.
ET Pharmaceuticals trading as Help Me Stop is the pharmacy marketing group for pharmacy ET Research Pty Ltd trading as Precision Pharmacy.
Copyright © 2026 Help Me Stop
This website requires you to be 18 years of age or older. Please verify your age to view content.
